scholarly journals Quality of Life in Hepatocellular Carcinoma Patients Treated with Transarterial Chemoembolization

HPB Surgery ◽  
2016 ◽  
Vol 2016 ◽  
pp. 1-9 ◽  
Author(s):  
Saleem Ahmed ◽  
Nurun Nisa de Souza ◽  
Wang Qiao ◽  
Meidai Kasai ◽  
Low Jee Keem ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Hepatocellular Carcinoma ◽  
Transarterial Chemoembolization ◽  
Palliative Therapy ◽  
Advanced Stages ◽  
The Impact

Hepatocellular carcinoma (HCC) is one of the most commonly diagnosed cancers worldwide. Majority of patients with HCC are diagnosed in the advanced stages of disease and hence they are only suitable for palliative therapy. TACE (transarterial chemoembolization) is the most commonly used treatment for unresectable HCC. It is however unclear if TACE improves the quality of life (QoL) in patients with HCC. The aim of this review is to evaluate the impact of TACE on QoL of HCC patients.

Symptom Control in Patients With Recurrent Ovarian Cancer: Measuring the Benefit of Palliative Chemotherapy in Women With Platinum Refractory/Resistant Ovarian Cancer

2009 ◽  
Vol 19 (Suppl 2) ◽  
pp. S44-S48 ◽  
Author(s):  
Michael Friedlander ◽  
Phyllis Butow ◽  
Martin Stockler ◽  
Corona Gainford ◽  
Julie Martyn ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Ovarian Cancer ◽  
Symptom Control ◽  
Objective Response ◽  
Palliative Therapy ◽  
Resistant Refractory ◽  
Platinum Resistant ◽  
Number Of Patients ◽  
The Impact

Most women with advanced ovarian cancer will relapse and subsequently develop platinum-resistant/refractory ovarian cancer. The benefit of treatment is currently based on objective response rates, which are a crude measure of benefit. It would be clinically meaningful if we were better able to measure the benefit of palliative therapy and, in particular, ascertain whether cancer-related symptoms improve with treatment and how this impacts on quality of life. This paper reviews the management of patients with platinum-resistant/refractory ovarian cancer and highlights the gaps in our knowledge and shortcomings with the current approaches to measure the benefit of treatment. The ultimate objective is to describe and encourage recruitment to the Gynecologic Cancer Intergroup study that has recently opened. This study will recruit a large number of patients from around the world in an effort to develop more robust instruments to measure the benefit of chemotherapy and to understand the impact of chemotherapy on symptom control and quality of life. In addition, this study will give us an insight into how all patients are managed rather than a select minority who are treated in clinical trials.

scholarly journals The impact of hepatocellular carcinoma diagnosis on patients' health‐related quality of life

2021 ◽  
Author(s):  
Manisha Verma ◽  
James M. Paik ◽  
Issah Younossi ◽  
Daisong Tan ◽  
Hala Abdelaal ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Hepatocellular Carcinoma ◽  
Health Related Quality ◽  
Related Quality ◽  
Health Related ◽  
The Impact

scholarly journals Impact of Alzheimer’s Dementia on Caregivers and Quality Improvement through Art and Music Therapy

Healthcare ◽  
2021 ◽  
Vol 9 (6) ◽  
pp. 698
Author(s):  
Laura-Cristina Popa ◽  
Mihnea Costin Manea ◽  
Diana Velcea ◽  
Ion Șalapa ◽  
Mirela Manea ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Art Therapy ◽  
Thinking Skills ◽  
General Term ◽  
Pharmacological Interventions ◽  
Advanced Stages ◽  
Somatic Disorders ◽  
The Impact ◽  
The Brain

Dementia is a general term for a series of medical conditions that affect the brain and evolve progressively. According to the literature, there are over 200 subtypes and causes of dementia, with Alzheimer’s disease (AD) being the most common in elderly people. AD is an irreversible progressive neurodegenerative condition that leads to a decline in mental function, enough to disrupt daily life. Thinking skills slowly deteriorate, which, in advanced stages, makes it impossible to perform simple tasks. Besides the change in the quality of life of AD patients and their families, there is a considerable alteration in the quality of life of their caregivers, whose health can be negatively affected by the development of mental and somatic disorders. This article reviews the literature in order to reveal the benefits of applying non-pharmacological interventions such as music and art therapy to improve quality of life. This article also aims to shed light on the impact of this disease on the caregiver’s life. Music and art therapy have produced reliable results in the treatment of patients with AD, and the best effects are related to increased socialization and the maintenance of social status.

Living with hepatocellular carcinoma from the patient perspective: A longitudinal study.

2014 ◽  
Vol 32 (3_suppl) ◽  
pp. 373-373 ◽  
Author(s):  
Lissi Hansen ◽  
Gina M. Vaccaro ◽  
Susan J. Rosenkranz
Keyword(s):  
Quality Of Life ◽  
Hepatocellular Carcinoma ◽  
End Of Life ◽  
Symptom Management ◽  
Illness Perceptions ◽  
Qualitative Description ◽  
Qualitative Approaches ◽  
The Impact ◽  
Over Time

373 Background: Hepatocellular carcinoma (HCC) is a growing problem. For those diagnosed with terminal HCC, there is no curative treatment. Despite a high death rate, no longitudinal studies were found examining the illness experience of patients with HCC as they are approaching death. The aim of this study was to describe the experience of living with terminal HCC and how it may affect end of life care from the perspective of patients. Methods: This was a longitudinal, prospective mixed methods pilot study using quantitative and qualitative approaches. Semi-structured interviews were conducted with a convenience sub-sample of 14 patients with HCC once a month for a 6-month period. The interview guide included questions about living with HCC, pain and symptom management strategies, treatment decisions, and any current concerns of significance. Interview data were analyzed using qualitative description. Results: This poster reports on qualitative analysis of 45 interviews from the sub-sample. Eleven patients were male and 3 were female (mean age=61.5, range=54-68 years). Findings included 4 major themes: 1) illness perceptions, 2) uncertainty about treatments over time, 3) quality of life, and 4) coping strategies. Patients perceived HCC as isolating as compared to other cancers. Patients lacked information to prepare them for the journey ahead. They struggled with symptom management over time and chose to stop treatment, delay treatment in hope of improvement, or regretted starting treatment once underway. Conclusions: For patients, the impact of HCC and treatment side effects on quality of life was challenging and filled with uncertainty. From this first step, knowledge gained is serving as the foundation for a proposed larger scale study. The goal is to develop future interventions to address challenges (e.g., symptom management and treatment decision making) at the end of life for these understudied cancer patients.

Sign in / Sign up

Export Citation Format

Share Document